Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
672.9±55.0 °C at 760 mmHg
HS Code Reference
Personal Projective Equipment
For Reference Standard and R&D, Not for Human Use Directly.
provides coniferyl ferulate(CAS#:333798-10-0) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of coniferyl ferulate are included as well.>> amp version: coniferyl ferulate
To describe inpatient course and length of hospital stay (LOS) for people who sustain brain disorders nationwide.
We interviewed 1,903 randomly selected community-dwelling patients registered as ‘disabled by brain disorders’ in 28 regions of South Korea.
Seventy-seven percent were initially admitted to a Western medicine hospital, and 18% were admitted to a traditional Oriental medicine hospital. Forty-three percent were admitted to two or more hospitals. Mean LOS was 192 days. Most patients stayed in one hospital for more than 4 weeks. The transfer rate to other hospitals was 30-40%. Repeated admissions and increased LOS were related to younger onset age, higher education, non-family caregiver employment, smaller families, and more severe disability.
Korean patients with brain disorders showed significantly prolonged LOS and repeated admissions. Factors increasing burden of care influenced LOS significantly.
Inpatients, Length of stay, Discharge, Stroke, Brain diseases
Inpatient Course and Length of Hospital Stay in Patients with Brain Disorders in South Korea: A Population-based Registry Study
Se Hee Jung, M.D., Ph.D., Kyoung Moo Lee, M.D., Ph.D.,1 Si-Woon Park, M.D.,2 Min Ho Chun, M.D., Ph.D.,3 Han Young Jung, M.D., Ph.D.,4 Il-soo Kim, M.D.,5 Se Hyun Kim, Ph.D.,6 and Tai Ryoon Han, M.D., Ph.D.corresponding author7